Zocor Dangerous In High Doses, FDA Warns

Law360, New York (June 9, 2011, 7:08 PM EDT) -- The U.S. Food and Drug Administration announced Wednesday that use of the highest-approved dose of Zocor carries an elevated risk of muscle injury, recommending that no new patients take the Merck & Co. Inc. cholesterol-lowering drug in that amount.

Only those patients who have taken Zocor or its generic form, simvastatin, for a year or more and have not experienced muscle toxicity should continue taking 80-milligram doses, the agency said in a statement.

Use of the drug at the dosage can lead to myopathy, a muscular...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.